Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Radiodermatitis × epigallocatechin gallate × Clear all

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leiomyoma 4 Papillomavirus Infections 2 Triple Negative Breast Neoplasms 1 Radiodermatitis 1 Prostatic Neoplasms 1 Papilloma 1 Liver Neoplasms 1 Liver Cirrhosis 1 Inflammation 1 Frailty 1 Fibrosis 1 Esophageal Neoplasms 1 Deglutition Disorders 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1

Interventions

Low-Level Light Therapy 6 Standard of Care 5 Petrolatum 3 Norepinephrine 3 triethanolamine 2 sapropterin 2 Curcumin 2 Biafine 2 eucerin 1 epigallocatechin gallate 1 dimethicone 1 cetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotion 1 calcipotriene 1 Zinc Oxide 1 Triamcinolone Acetonide 1 Thioctic Acid 1 Sodium Hypochlorite 1 Sodium Chloride 1 Silver Sulfadiazine 1 Radiotherapy, Conformal 1 Radiotherapy 1 Practice Guidelines as Topic 1 Melatonin 1 Laser Therapy 1 Hydrogel, Polyethylene Glycol Dimethacrylate 1 Hydrocortisone 1 Gels 1 Dimethyl Sulfoxide 1 Catechin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07149506 2025-09-08

OCTOPUS-RD

Universidad de Guanajuato

Phase 3 Enrolling by invitation

Fibrosis, Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡